Feasibility of measuring the prognostic factors uPA and PAI-1 in core needle biopsy breast cancer specimens.
Thomssen
Christoph
C
Harbeck
Nadia
N
Dittmer
Juergen
J
Abraha-Spaeth
Shanti R
SR
Papendick
Nancy
N
Paradiso
Angelo
A
Lisboa
Bjoern
B
Jaenicke
Fritz
F
Schmitt
Manfred
M
Vetter
Martina
M
D014408:Biomarkers, Tumor / Q000032:analysis*; D001707:Biopsy, Needle; D001943:Breast Neoplasms / Q000737:chemistry*; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D017395:Plasminogen Activator Inhibitor 1 / Q000032:analysis*; D011379:Prognosis; D012307:Risk Factors; D014568:Urokinase-Type Plasminogen Activator / Q000032:analysis*
D014408:Biomarkers, Tumor; D017395:Plasminogen Activator Inhibitor 1; D014568:Urokinase-Type Plasminogen Activator